London: The UK government on Wednesday added Covishield, the Indian-manufactured Oxford/AstraZeneca COVID-19 vaccine, to an updated international travel advisory.
However, while the UK has approved Covishield, it has raised concerns over ‘vaccine certification’ in India. This implies that those fully-vaccinated with Covishield will still need to quarantine in the UK despite the fact that the country was added to the ‘amber list’ according to the latest travel rules.
“Formulations of the 4 listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, qualify as approved vaccines,” reads the advisory from the UK’s Department for Transport (DfT) and Department of Health and Social Care (DHSC).
According to the updated advisory, from 4 am on October 4, those who have taken vaccines from a “relevant public health body” in specific countries will be considered “fully vaccinated”, and India does not feature on this list.
“You must have had a complete course of an approved vaccine at least 14 days before you arrive in England,” it adds.
The move follows widespread condemnation of the Serum Institute of India manufactured vaccines not being included in a list of eligible COVID-19 vaccines recognised under Britain’s reviewed international travel norms, effective from October 4.
From October 4, the current traffic light system of red, amber and green countries based on levels of COVID-19 risk will be scrapped and replaced with one red list only.
ALSO WATCH: Is India Entering The Endemic Stage | Explained